Users Discontinuing Anti-Obesity Jabs Gain Back Pounds Four Times Faster Than Those on Conventional Diets

A recent study suggests that individuals who stop using blockbuster slimming jabs like Wegovy and Mounjaro can put back on shed pounds far faster than those who stop traditional diet and exercise regimens.

Research printed in a major medical journal points out that while overweight people can lose substantial amounts of their body weight while undergoing treatment, the weight is regained at an estimated rate of nearly a kilo each month after stopping.

"Users purchasing such medications should be informed of the risk of quick weight regain when the therapy is stopped," warns lead investigator Dr. Susan Jebb.

That rate of recovery suggests a reversion to pre-treatment weight in about 18 months.

Analyzing Therapies

The research, which examined dozens of studies involving thousands of participants, contrasted the outcomes of GLP-1 agonists with conventional dieting.

Scientists note that individuals who shed pounds through diet and exercise typically see a less rapid weight regain—approximately 0.1 kg a month—once they finish.

Understanding the Fast Regain

Doctors believe the mode of action of the drugs explains the accelerated regain.

The injections imitate a body's own chemical called GLP-1, which helps regulate appetite.

"Artificially providing GLP-1 levels several times higher than the body's typical production could lead to the system to generate a reduced amount of its own natural GLP-1, and may also lessen sensitivity to its effects," explained Dr. Adam Collins, a nutrition specialist.

"Withdrawal of this GLP-1 'fix' leads to hunger is uncontrolled, making binge eating a significant risk."

A Chronic Disease?

The NHS recommend the jabs for individuals with obesity-related health risks, accompanied by recommended lifestyle changes.

A number of clinicians say that, given the likelihood of relapse, the therapy is often long-term.

This opinion is supported by drug manufacturers, who say that the results "underscore the persistent nature of excess weight," similar to managing diseases like high blood pressure.

Patient Experiences

Users who have come off the medication describe a sudden resurgence of hunger.

"It felt as if something that goes on and you become extremely hungry," described a patient.

The struggle is worsened if individuals have not adopted sustainable lifestyle or habit modifications during therapy.

Widespread Use

Survey data suggest that millions of adults in the UK have tried weight-loss jabs in the past year, with desire being substantial.

• Use is higher among females compared to males.
• The middle-aged demographic shows the highest level of interest.
• Many access the medications through private healthcare rather than public health services.

In conclusion, clinicians caution that while GLP-1 drugs are effective tools for shedding pounds, they are not a permanent solution and maintained weight loss hinges on integrated lifestyle management.